ArticleAnnals of hematology2026

Donor lymphocyte infusions for recurrence of myeloid neoplasms after allogeneic hematopoietic cell transplantation in the era of hypomethylating agents and BCL2 inhibitors.

Miriam Mozaffari Jovein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.